Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Molina HealthcareFRA:MHG -1.40%77 Debt-to-EBITDA is 5.34 as of Jun. 2026, which is 212% above its 10-year median of 1.71. GuruFocus rates FRA:MHG with a GF Score™ of 77/100 and a GF Value™ of €336.14 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 13 Healthcare Plans companies, Molina Healthcare ranks worse than 100% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Molina Healthcare's Debt-to-EBITDA or its related term are showing as below:
FRA:MHG'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -6.86 Med: 1.71 Max: 10.66
Current: 10.66
During the past 13 years, the highest Debt-to-EBITDA Ratio of Molina Healthcare was 10.66. The lowest was -6.86. And the median was 1.71.
FRA:MHG's Debt-to-EBITDA is ranked worse than 100% of 13
companies
in the Healthcare Plans industry
Industry Median: 3.41
vs FRA:MHG: 10.66
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Molina Healthcare Debt-to-EBITDA Related Terms
Molina Healthcare Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Molina Healthcare's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MHG vs OSCR, ALHC, PGNY: Debt-to-EBITDA Comparison
For the Healthcare Plans subindustry, Molina Healthcare's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Molina Healthcare Debt-to-EBITDA vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Molina Healthcare's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Molina Healthcare's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Molina Healthcare (FRA:MHG) has a Debt-to-EBITDA of 5.34 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Molina Healthcare. This is 212% above median its historical median of 1.71. According to the industry distribution chart, Molina Healthcare ranks #13 out of 13 companies in the Healthcare Plans industry.
Is Molina Healthcare's Debt-to-EBITDA too high?
Molina Healthcare's current Debt-to-EBITDA of 5.34 is 212% above median its 10-year median of 1.71. The Healthcare Plans industry median Debt-to-EBITDA is 3.41. Molina Healthcare's value of 5.34 is 56.6% above this industry median. Based on the distribution chart, Molina Healthcare ranks #13 out of 13 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, Molina Healthcare has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Molina Healthcare's Debt-to-EBITDA compare to OSCR and ALHC?
According to the Healthcare Plans industry distribution chart, Molina Healthcare ranks #13 out of 13 companies for Debt-to-EBITDA. This places Molina Healthcare in the lower half of its industry. The industry median Debt-to-EBITDA is 3.41. Molina Healthcare's value of 5.34 is 56.6% above this benchmark. While the company's 10-year median is 1.71 vs. the industry median of 3.41, Molina Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Plans company?
The median Debt-to-EBITDA among Healthcare Plans companies is 3.41, based on 13 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Molina Healthcare's current Debt-to-EBITDA of 5.34 is 56.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Molina Healthcare. For the Healthcare Plans industry, the median Debt-to-EBITDA is 3.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Molina Healthcare's current Debt-to-EBITDA is 5.34, which is 212% above median its own 10-year median of 1.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molina Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Molina Healthcare (FRA:MHG) is currently considered Significantly Undervalued. The stock's GF Value™ is €336.14, compared to a current price of €165.70 — trading 50.7% below its estimated fair value. The current Debt-to-EBITDA is 5.34, which is 212% above median its 10-year median of 1.71 and 56.6% above the Healthcare Plans industry median of 3.41. Molina Healthcare's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Molina Healthcare (FRA:MHG), the current Debt-to-EBITDA is 5.34 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Molina Healthcare (FRA:MHG) Overvalued in 2026?
Based on GuruFocus' analysis, Molina Healthcare stock appears to be undervalued.
The current stock price of €165.70 is trading 50.7% below its estimated GF Value™ of €336.14.
GuruFocus considers Molina Healthcare to be Significantly Undervalued.
Key valuation signals for FRA:MHG:
Debt-to-EBITDA: 5.34 (212% above median its 10-year median of 1.71)
GF Value™: €336.14 vs. price of €165.70 (50.7% below fair value)
Industry Position: 56.6% above the Healthcare Plans median (#13 of 13)
No single metric tells the full story. See the FRA:MHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.
77GF Score
Get the complete analysis for FRA:MHG
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MHG has been successfully added to your 
